nodes	percent_of_prediction	percent_of_DWPC	metapath
Clemastine—Loperamide—POMC—polycystic ovary syndrome	0.0456	0.333	CrCbGaD
Clemastine—Azelastine—ADRA1B—polycystic ovary syndrome	0.0395	0.289	CrCbGaD
Clemastine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.0229	0.167	CrCbGaD
Clemastine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.0154	0.113	CrCbGaD
Clemastine—Azelastine—CYP1A1—polycystic ovary syndrome	0.0136	0.0991	CrCbGaD
Clemastine—Chest discomfort—Metformin—polycystic ovary syndrome	0.0111	0.11	CcSEcCtD
Clemastine—Nasal congestion—Metformin—polycystic ovary syndrome	0.00782	0.0778	CcSEcCtD
Clemastine—Sweating increased—Metformin—polycystic ovary syndrome	0.00599	0.0597	CcSEcCtD
Clemastine—Drowsiness—Metformin—polycystic ovary syndrome	0.00549	0.0546	CcSEcCtD
Clemastine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00538	0.0536	CcSEcCtD
Clemastine—Chills—Metformin—polycystic ovary syndrome	0.00442	0.044	CcSEcCtD
Clemastine—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00431	0.00566	CbGpPWpGaD
Clemastine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00415	0.00544	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.00413	0.00541	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00411	0.00538	CbGpPWpGaD
Clemastine—Vision blurred—Metformin—polycystic ovary syndrome	0.00404	0.0402	CcSEcCtD
Clemastine—HRH1—IL-4 Signaling Pathway—IRS1—polycystic ovary syndrome	0.00404	0.0053	CbGpPWpGaD
Clemastine—Tremor—Metformin—polycystic ovary syndrome	0.00402	0.04	CcSEcCtD
Clemastine—HRH1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00401	0.00525	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00399	0.00523	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1A—polycystic ovary syndrome	0.00397	0.0052	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00389	0.00511	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00388	0.00508	CbGpPWpGaD
Clemastine—Palpitations—Metformin—polycystic ovary syndrome	0.00379	0.0377	CcSEcCtD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00375	0.00492	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00369	0.00484	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00362	0.00475	CbGpPWpGaD
Clemastine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00353	0.00464	CbGpPWpGaD
Clemastine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00349	0.00457	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00343	0.0045	CbGpPWpGaD
Clemastine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00343	0.0341	CcSEcCtD
Clemastine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00338	0.0337	CcSEcCtD
Clemastine—HRH1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00334	0.00438	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00334	0.00438	CbGpPWpGaD
Clemastine—Anorexia—Metformin—polycystic ovary syndrome	0.00334	0.0332	CcSEcCtD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.0033	0.00433	CbGpPWpGaD
Clemastine—Hypotension—Metformin—polycystic ovary syndrome	0.00327	0.0326	CcSEcCtD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00321	0.00421	CbGpPWpGaD
Clemastine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00314	0.0313	CcSEcCtD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00314	0.00412	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00313	0.0041	CbGpPWpGaD
Clemastine—Somnolence—Metformin—polycystic ovary syndrome	0.00311	0.031	CcSEcCtD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.0031	0.00406	CbGpPWpGaD
Clemastine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00308	0.0307	CcSEcCtD
Clemastine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00304	0.0303	CcSEcCtD
Clemastine—HRH1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00304	0.00398	CbGpPWpGaD
Clemastine—Fatigue—Metformin—polycystic ovary syndrome	0.00302	0.03	CcSEcCtD
Clemastine—Constipation—Metformin—polycystic ovary syndrome	0.00299	0.0298	CcSEcCtD
Clemastine—HRH1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00295	0.00387	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00294	0.00386	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00294	0.00385	CbGpPWpGaD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00292	0.00383	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00292	0.00382	CbGpPWpGaD
Clemastine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00288	0.0287	CcSEcCtD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00288	0.00378	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00287	0.00376	CbGpPWpGaD
Clemastine—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00286	0.00375	CbGpPWpGaD
Clemastine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00285	0.00374	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00283	0.00371	CbGpPWpGaD
Clemastine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00281	0.00369	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.0028	0.00367	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00279	0.00365	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00273	0.00358	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00255	0.00334	CbGpPWpGaD
Clemastine—Asthenia—Metformin—polycystic ovary syndrome	0.00251	0.025	CcSEcCtD
Clemastine—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.0025	0.00328	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.0025	0.00328	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00249	0.00327	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00245	0.00321	CbGpPWpGaD
Clemastine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00239	0.0238	CcSEcCtD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00237	0.0031	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00234	0.00306	CbGpPWpGaD
Clemastine—Dizziness—Metformin—polycystic ovary syndrome	0.00231	0.023	CcSEcCtD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00231	0.00303	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00231	0.00303	CbGpPWpGaD
Clemastine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.0023	0.00302	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.0023	0.00302	CbGpPWpGaD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00228	0.00299	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00226	0.00297	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00224	0.00293	CbGpPWpGaD
Clemastine—Vomiting—Metformin—polycystic ovary syndrome	0.00222	0.0222	CcSEcCtD
Clemastine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00222	0.00291	CbGpPWpGaD
Clemastine—Headache—Metformin—polycystic ovary syndrome	0.00219	0.0218	CcSEcCtD
Clemastine—HRH1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00215	0.00282	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00213	0.00279	CbGpPWpGaD
Clemastine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00212	0.00279	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00208	0.00273	CbGpPWpGaD
Clemastine—Nausea—Metformin—polycystic ovary syndrome	0.00208	0.0207	CcSEcCtD
Clemastine—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00207	0.00271	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00206	0.0027	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00205	0.00268	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00204	0.00268	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.002	0.00263	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.002	0.00263	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00199	0.00262	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00193	0.00253	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00192	0.00252	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.0019	0.0025	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.0019	0.00249	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00189	0.00248	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00189	0.00248	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00187	0.00246	CbGpPWpGaD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00186	0.00244	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00186	0.00244	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00185	0.00242	CbGpPWpGaD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00184	0.00241	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00178	0.00234	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00177	0.00232	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00172	0.00226	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00172	0.00225	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00172	0.00225	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00172	0.00225	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00167	0.00219	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00164	0.00215	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.0016	0.0021	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00156	0.00204	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00153	0.002	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00153	0.002	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00152	0.002	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00152	0.00199	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00152	0.00199	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00151	0.00198	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00151	0.00197	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.0015	0.00197	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00141	0.00184	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00139	0.00182	CbGpPWpGaD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00139	0.00182	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00138	0.00181	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00138	0.00181	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00135	0.00177	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00133	0.00175	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00126	0.00166	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00126	0.00165	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00126	0.00165	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00126	0.00165	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00124	0.00163	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00123	0.00161	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00122	0.0016	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00121	0.00159	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00121	0.00159	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.0012	0.00158	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00118	0.00154	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00116	0.00153	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00115	0.00151	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00113	0.00148	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00113	0.00148	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00111	0.00145	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.0011	0.00144	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00109	0.00143	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.00108	0.00142	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00108	0.00141	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00108	0.00141	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00107	0.0014	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00102	0.00134	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00101	0.00133	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00101	0.00133	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000995	0.0013	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000987	0.00129	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000987	0.00129	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000982	0.00129	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000977	0.00128	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000954	0.00125	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000948	0.00124	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00092	0.00121	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000918	0.0012	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000915	0.0012	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000895	0.00117	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000872	0.00114	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000814	0.00107	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000802	0.00105	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000794	0.00104	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000791	0.00104	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.00078	0.00102	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.00078	0.00102	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000742	0.000973	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000726	0.000952	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000721	0.000946	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000706	0.000925	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000697	0.000915	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000678	0.00089	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FST—polycystic ovary syndrome	0.000661	0.000867	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000657	0.000862	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000654	0.000857	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000653	0.000856	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000645	0.000846	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000645	0.000846	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000645	0.000846	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000631	0.000827	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.00062	0.000813	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000611	0.000801	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00061	0.000799	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000605	0.000793	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.0006	0.000787	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000598	0.000784	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000597	0.000783	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000591	0.000775	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000577	0.000756	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000567	0.000743	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000562	0.000737	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00056	0.000734	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000554	0.000726	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000527	0.000691	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000525	0.000688	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000518	0.000679	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.00051	0.000669	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.00051	0.000669	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000503	0.000659	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000495	0.000649	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00047	0.000617	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000463	0.000607	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000459	0.000601	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000458	0.000601	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000448	0.000588	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000434	0.000569	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000428	0.000561	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000426	0.000559	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000426	0.000559	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00041	0.000538	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000406	0.000533	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000405	0.000531	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000399	0.000524	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000396	0.00052	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000395	0.000517	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000387	0.000507	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000387	0.000507	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000375	0.000492	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000373	0.000489	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000373	0.000489	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000372	0.000487	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000358	0.00047	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000358	0.00047	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000354	0.000464	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000353	0.000462	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000345	0.000452	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000334	0.000438	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000329	0.000431	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000329	0.000431	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000327	0.000429	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000312	0.000408	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000306	0.000401	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.0003	0.000393	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000293	0.000384	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.000285	0.000373	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000284	0.000372	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000277	0.000363	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000262	0.000343	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000261	0.000342	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	0.00026	0.000341	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000256	0.000336	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.000253	0.000332	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000244	0.00032	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000234	0.000307	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	0.000232	0.000305	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000231	0.000303	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000229	0.0003	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	0.000221	0.00029	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	0.00022	0.000289	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	0.000219	0.000287	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000218	0.000286	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000215	0.000282	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000212	0.000278	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000212	0.000278	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	0.00021	0.000275	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000201	0.000264	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	0.000196	0.000257	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	0.000186	0.000244	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000181	0.000237	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	0.00017	0.000223	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000162	0.000212	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	0.000159	0.000208	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	0.000156	0.000205	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	0.000156	0.000204	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	0.000152	0.000199	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	0.000145	0.00019	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000138	0.000181	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000137	0.00018	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	0.000128	0.000168	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	0.000104	0.000136	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	0.000102	0.000134	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	0.000102	0.000133	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	9.57e-05	0.000125	CbGpPWpGaD
